<scp>ZT</scp> ‐01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes-Reference-Cited by-同舟云学术

ZT ‐01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes

Published:2022-02-15 Issue:5 Volume:24 Page:908-917
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Farhat Rawad¹,Aiken Julian²,D'Souza Ninoschka C.²,Appadurai Daniel¹,Hull Grayson¹,Simonson Eric³,Liggins Richard T.³,Riddell Michael C.²³^ORCID,Chan Owen¹^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetes University of Utah Salt Lake City Utah USA

2. School of Kinesiology and Health Science York University Toronto Ontario Canada

3. Zucara Therapeutics Vancouver British Columbia Canada

Funder

Juvenile Diabetes Research Foundation International

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14652

Reference40 articles.

1. Hypoglycemia: Still The Limiting Factor in the Glycemic Management of Diabetes

2. Glucose counterregulation: prevention and correction of hypoglycemia in humans;Cryer PE;Am J Physiol.,1993

3. Hierarchy of Physiological Responses to Hypoglycemia: Relevance to Clinical Hypoglycemia in Type I (Insulin Dependent) Diabetes Mellitus*

4. The Barrier of Hypoglycemia in Diabetes

5. Hypoglycemia in IDDM

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice;World Journal of Diabetes;2024-08-15

2. The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes;International Journal of Molecular Sciences;2024-04-06

3. Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes;Frontiers in Pharmacology;2024-02-28

4. Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes;Frontiers in Pharmacology;2024-01-17

5. (Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise;Diabetes Technology & Therapeutics;2023-12-22